Характеристика предсердной эктопии и оптимизация интервенционного лечения у больных пароксизмальной фибрилляцией предсердий

Список литературы

1. Лебедев Д.С., Маринин В. А., Оршанская B.C. Остиальная аблация легочных вен у пациентов с разными формами фибрилляции предсердий // Вестник Аритмологии. 2006. — № 45. — С.35−41.
2. Лебедев Д.С., Михайлов Е. Н., Оршанская B.C., Маринин В. А. Селективная аблация устьев «аритмогенных» легочных вен в лечении пароксизмаль-ной фибрилляции предсердий: клинический случай // Вестник Аритмологии. -2008.-№ 50.-С.66−69.
3. Покушалов Е.А., Туров А. Н., Шугаев П. Л. и др. Новый подход в лечении фибрилляции предсердий: катетерная аблация ганглионарных сплетений в левом предсердии // Вестник Аритмологии. 2006. — № 45. — С. 17−27.
4. Aime-Sempe С, Folliguet Т, Rucker-Martin С, et al. Myocardial cell death in fibrillating and dilated human right atria // J. Am. Coll. Cardiol. 1999. — V.34. -P. 1577−86.
5. Arentz T, von RJ, Blum T, Stockinger J, et. al. Feasibility and safety of pulmonary vein isolation using a new mapping and navigation system in patients with refractory atrial fibrillation // Circulation. 2003. — V.108. — P.2484 -2490.
6. Arora R, Verheule S, Scott L, et. al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping // Circulation. 2003. -V.107. -P.1816 -1821.
7. Atienza F, Almendral J, Moreno J, et al. Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans: evidence for a reentrant mechanism // Circulation. 2006. — V. l 14. — P.2434 -2442.
8. Ausma J, Litjens N, Lenders MH, et. al. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat // J. Mol. Cell. Cardiol. -2001. V.33. — P.2083—2094.
9. Ausma J, van der Velden HM, Lenders MH, et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat // Circulation. — 2003.-V.107.-P.2051−8.
10. Ausma J, Wijffels M, Thone F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat // Circulation. 1997. — V.96. -P.3157- 63.
11. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study // JAMA. — 1994. V.271. — P.840−4.
12. Berenfeld O, Mandapati R, Dixit S, et. al. Spatially distributed dominant excitation frequencies reveal hidden organization in atrial fibrillation in the Langen-dorff-perfused sheep heart // J. Cardiovasc. Electrophysiol. 2000. — V.ll. -P.869−879.
13. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation // Circulation. 2002. — V.105. — P.2753−2759.
14. Bharti S, Lev M. Histology of the normal and diseased atrium. In: Fall RH, Podrid PJ, editors. Atrial Fibrillation: Mechanism and Management // New York: Raven Press. 1992. — P. 15−39.
15. Boyden PA, Hoffman BF. The effects on atrial electrophysiology and structure of surgically induced right atrial enlargement in dogs // Circ. Res. 1981. -V.49. — P. 1319 -31.
16. Boyden PA, Tilley LP, Albala A, et al. Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease // Circulation. 1984. — V.69. — P. 1036−47.
17. Brand FN, Abbott RD, Kannel WB, et al. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study // JAMA. -1985. V.254. — P.3449 -53.
18. Brundel BJ, Ausma J, van Gelder IC. et al. Activation of proteolysis by cal-pains and structural changes in human paroxysmal and persistent atrial fibrillation // Cardiovasc. Res. 2002. — V.54,№ 2. — P.380−9.
19. Callans DJ, Gerstenfeld EP, Dixit S, et. al. Efficacy of repeat pulmonary vein isolation procedures in patients with recurrent atrial fibrillation // J. Cardiovasc. Electrophysiol. 2004. — V. 15. — P. 1050−1055.
20. Cappato R., Calkins H., Chen S.A. et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation // Circulation. 2005. — V.8, № 111(9). — P. l 100−5.
21. Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study // J. Am. Coll. Cardiol. 2003. — V.41. — P. 1690 -1696.
22. Chen SA, Tai CT. Catheter ablation of atrial fibrillation originating from the nonpulmonary vein foci // J. Cardiovasc. Electrophysiol. 2005. — V.16. — P.229 — 232.
23. Chen YJ, Chen SA. Electrophysiology of pulmonary veins // J. Cardiovasc. Electrophysiol. 2006. — V.17. — P.220 -224.
24. Chen YJ, Chen SA. Thoracic vein arrhythmias // Circ J. 2007. — V.71, Suppl. A. -P.A20−5.
25. Chevalier P., Obadia J.F., Timour Q. Et al. Thoracoscopic epicardial radiofre-quency ablation for vagal atrial fibrillation in dogs // Pacing Clin. Electrophysiol. -1999.-V.22. -P.880−886.
26. Chou CC, Zhou S, Tan AY, et. al. High-density mapping of pulmonary veins and left atrium during ibutilide administration in a canine model of sustained atrial fibrillation // Am. J. Physiol. Heart. Circ. Physiol. 2005. — V.289. — P. H2704-H2713.
27. Chung D. Electrical activity of the pulmonary vein and its interaction with the right atrium in the guinea pig // J. Physiol. 2006. — V.1980,№ 314. — P.445- 446.
28. Clark DM, Plumb VJ, Epstein AE, et. al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation // J .Am. Coll. Cardiol. 1997. — V.30.-P.1039−1045.
29. Corley SD, Epstein AE, DiMarco JP, et. al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study // Circulation. 2004. — V.109. -P.1509−1513.
30. Dobrev D, Friedrich A, Voigt N. et. al. The G protein-gated potassium current I (K, ACh) is constitutively active in patients with chronic atrial fibrillation // Circulation. 2005. — V. l 12. — P.3697−3706.
31. Evans W, Swann P. Lone auricular fibrillation // Br. Heart. J. V.1954,№ 16. -P.194.
32. Everett TH, Li H, Mangrum JM, et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation // Circulation. 2000. — V.102. — P. 1454−60.
33. Everett TH, Olgin JE. Basic mechanisms of atrial fibrillation // Cardiol. Clin. -2004.-V.22.-P.9−20.
34. Feinberg WM, Blackshear JL, Laupacis A. et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications // Arch. Intern. Med. 1995. — V. 155. — P.469 -73.
35. Feinberg WM, Seeger JF, Carmody RF. et al. Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation // Arch. Intern. Med. 1990. -V. 150. -P.2340−4.
36. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation published erratum appears in Lancet 1987- 1:878. // Lancet. 1987. — V.l. -P.526 -9.
37. Friberg J, Buch P, Scharling H. et al. Rising rates of hospital admissions for atrial fibrillation // Epidemiology. 2003. — V. 14. — P.666−72.
38. Frustaci A, Chimenti C, Bellocci F. et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation // Circulation. 1997. — V.96. — P. l 1804.
39. Frustaci A, Chimenti C, Bellocci F. et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation // Circulation. 1997. — V.96. — P. l 1804.
40. Furberg CD, Psaty BM, Manolio TA. et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) // Am. J. Cardiol. 1994. — V.74. — P.236−41.
41. Gerstenfeld EP, Callans DJ, Dixit S. et. al. Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation // Circulation. 2004. — V.110. — P. 1351−1357.
42. Gerstenfeld EP, Dixit S, Callans D. et. al. Utility of exit block for identifying electrical isolation of the pulmonary veins // J. Cardiovasc. Electrophysiol. 2002. -V.13.-P.971−979.
43. Gillinov AM, Bakaeen F, McCarthy PM. Et. al. Surgery for paroxysmal atrial fibrillation in the setting of mitral valve disease: a role for pulmonary vein isolation? // Ann. Thorac. Surg. 2006. — V.81. — P. 19 -26.
44. Gillinov AM, Bhavani S, Blackstone EH. et. al. Surgery for permanent atrial fibrillation: impact of patient factors and lesion set // Ann. Thorac. Surg. 2006. -V.82. -P.502−513.
45. Gittenberger-de Groot AC, Blom NM. Aoyama N. et. al The role of neural crest and epicardium-derived cells in conduction system formation // Novartis Found Symp. 2003. — V.250. — P. 125−134.
46. Gittenberger-de Groot AC, Blom NM, Aoyama N. et. al. The role of neural crest and epicardium-derived cells in conduction system formation // Novartis Found Symp. 2003. -V.250. — P. 125−134.
47. Goette A, Staack T, Rocken C. et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation // J. Am. Coll. Cardiol. 2000. — V.35. — P.1669−77.
48. Haissaguerre M, Hocini M, Sanders P. et al. Catheter ablation of longlasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias // J. Cardiovasc. Electrophysiol. 2005. — V.16. — P. 1138 -1147.
49. Haissaguerre M, Hocini M, Sanders P. et. al. Localized sources maintaining atrial fibrillation organized by prior ablation // Circulation. 2006. — V.113. -P.616−625.
50. Haissaguerre M, Jais P, Shah DC. et. al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci // Circulation. -2000. -V. 101. -V. 1409−1417.
51. Haissaguerre M, Jais P, Shah DC. et al. Right and left atrial radiofrequency catheter therapy of paroxysmal atrial fibrillation // J. Cardiovasc. Electrophysiol. -1996.-V.7.-P.1132−1144.
52. Haissaguerre M, Jais P, Shah DC. et. al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins // N. Engl. J. Med. — 1998. V.339. — P.659−666.
53. Haissaguerre M, Marcus FI, Fischer B, Clementy J. Radiofrequency catheter ablation in unusual mechanisms of atrial fibrillation: report of three cases // J. Car-diovasc. Electrophysiol. 1994. — V.5. — P.743−751.
54. Haissaguerre M, Sanders P, Hocini M. et. al. Catheter ablation of longlasting persistent atrial fibrillation: critical structures for termination // J. Cardiovasc. Electrophysiol. -2005. -V. 16. P. 1125−1137.
55. Haissaguerre M, Shah DC, Jais P. et. al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins // Circulation. 2000. — V.102. -P.2463—2465. '
56. Hart RG, Halperin JL. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention // Ann. Intern. Med. — 1999. — V.131. P.688−95.
57. Ho SY, Sanchez-Quintana D, Cabrera JA, Anderson RH. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation // J. Cardiovasc. Electrophysiol. 1999. — V. 10. — P. 1525−1533.
58. Hocini M, Ho SY, Kawara T. et. al. Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation // Circulation. — 2002. — V.105. P.2442−2448.
59. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial // Lancet. 2000. — V.356. — P.1789 -1794.
60. Jais P, Cauchemez B, MacLe L. et. al. Atrial fibrillation ablation vs antiarrhythmic drugs: A multicenter randomized trial // Heart Rhythm. 2006. -V.3(Suppl). — P. S 1-S460.
61. Jais P, Haissaguerre M, Shah DC. et. al. Regional disparities of endocardial atrial activation in paroxysmal atrial fibrillation // Pacing Clin. Electrophysiol. — 1996. V.19(ll Pt 2).-P. 1998−2003.
62. Jais P, Haissaguerre M, Shah DC. et. al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation // Circulation. 1997. — V.95. — P.572−576.
63. Jais P, Hocini M, MacLe L. et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation // Circulation. — 2002. — V.106. — P.2479 -2485.
64. Jalife J, Berenfeld O, Mansour M. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation // Cardiovasc. Res. 2002. — V.54. — P.204−216
65. Jongbloed MR, Schalij MJ, Poelmann RE. et. al. Embryonic conduction tissue: a spatial correlation with adult arrhythmogenic areas // J. Cardiovasc. Electro-physiol. 2004. — V. 15. — P.349 -355.
66. Kalifa J, Jalife J, Zaitsev AV. et. al. Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation // Circulation. 2003. — V.108. — P.668−671.
67. Kalifa J, Tanaka K, Zaitsev AV. et al. Mechanisms of wave fractionation at boundaries of high-frequency excitation in the posterior left atrium of the isolated sheep heart during atrial fibrillation // Circulation. 2006. — V. l 13. — P.626−633.
68. Karch MR, Zrenner B, Deisenhofer I. et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies // Circulation. 2005. — V. l 11. — P.2875−2880.
69. Katritsis D.G., Ellenbogen K.A. Is isolation of all four pulmonary veins necessary in patients with paroxysmal atrial fibrillation? // Pacing Clin. Electro-physiol. 2004. — V.27, № 7. — P.938−40.
70. Katritsis D.G., Ellenbogen K.A., Panagiotakos D.B. et al. Ablation of superior pulmonary veins compared to ablation of all four pulmonary veins // J. Cardiovasc. Electrophysiol. 2004. — V. l5, № 6. -P.641−5.
71. Kempster PA, Gerraty RP, Gates PC. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation // Stroke. 1988. — V. l9. — P.955−7.
72. Kistler P.M., Kaiman J.M. et al. Locating focal atrial tachycardias from P-wave morphology // Heart Rhythm. 2005. — V.2, № 5. — P.561−564
73. Kistler P.M., Sanders P., Fynn S.P. et al. Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins // Circulation. 2003. — V.108. — P. 1968−1975.
74. Konings KT, Smeets JL, Penn OC. et. el. Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans // Circulation. 1997. — V.4,№ 95. -P.1231−1241.
75. Kopecky SL, Gersh BJ, McGoon MD. et al. The natural history of lone atrial fibrillation. A population-based study over three decades // N. Engl. J. Med. -1987. V.317. -P.669 -74.
76. Krahn AD, Manfreda J, Tate RB. et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study // Am. J. Med. 1995.- V.98.-P.476−84.
77. Lazar S, Dixit S, Marchlinski FE. et. al. Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans // Circulation. 2004. — V. 110. — P.3181−3186.
78. Le Heuzey JY, Paziaud O, Piot O. et al. Cost of care distribution in atrial fibrillation patients: the COCAF study // Am. Heart. J. 2004. — V.147. — P. 121- 6.
79. Lebedev D., Mikhaylov E., Gureev S., Savello V.E. Pulmonary veins stenoses after selective catheter ablation of ganglionated plexi // Journal of Interventional Cardiac Electrophysiology. -2008. V.20. — Suppl. 1. -P1506.
80. Lee SH, Tai CT, Hsieh MH. et al. Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implication for catheter ablation // J. Am. Coll. Cardiol. -2005. -V.46. P. 1054−1059.
81. Lemola K, Ting M, Gupta P. et al. Effects of two different catheter ablation techniques on spectral characteristics of atrial fibrillation // J. Am. Coll. Cardiol. — 2006. V.48. — P.340−348.
82. Lemola K., Hall B., Cheung P. et al. Mechanisms of recurrent atrial fibrillation after pulmonary vein isolation by segmental ostial ablation // Heart Rhythm. -2004.-V.l. 197−202.
83. Leone O, Boriani G, Chiappini B. et al. Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation // Eur. Heart J. 2004. -V.25. -P.1237−41.
84. Levy S, Maarek M, Coumel P. et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists // Circulation. 1999. — V.99. — P.3028 -35.
85. Levy S. Factors predisposing to the development of atrial fibrillation // Pacing Clin. Electrophysiol. 1997. — V.20. — P.2670−4.
86. Li D, Fareh S, Leung TK. et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort // Circulation. 1999. — V.100. -P.87−95.
87. Lin D, Beldner S, Vanderhoff M. et al. Provocability of atrial fibrillation triggers during pulmonary vein isolation in patients with infrequent AF // Heart Rhythm. 2004. — V. 1 (Suppl). — P. S231.
88. Lin D. Provocability of atrial fibrillation triggers during pulmonary vein isolation in patients with infrequent AF // Heart Rhythm. 2004. — V. l (Suppl). -P.S231.
89. Lin WS, Tai CT, Hsieh MH. et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy // Circulation. 2003. — V. l07. -P.3176 -3183.
90. Maixent JM, Paganelli F, Scaglione J. et al. Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation // J. Cardiovasc. Electrophysiol. 1998. — V.9. -P.612−7.
91. Mandapati R, Skanes A, Chen J. et. al. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart // Circulation. 2000. -V.101. — P.194 -199.
92. Mansour M, Mandapati R, Berenfeld O. et. al. Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart // Circulation. 2001. — V. 103. — P.2631−2636.
93. Marrouche NF, Martin DO, Wazni O. et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications // Circulation. 2003. — V.107. -P.2710−2716.
94. Mary-Rabine L, Albert A, Pham TD. et al. The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure // Cire. Res. -1983. -V.52.- P. 188−99.
95. Melo J, Adragao P, Neves J. et al. Surgery for atrial fibrillation using radiof-requency catheter ablation: assessment of results at one year // Eur. J. Cardiotho-rac. Surg. 1999.- V. 15.- P.851−854.
96. Mikhaylov E., Lebedev D., Gureev S.V., Marinin V.A. Misleading interpolated premature atrial contractions in patients with paroxysmal atrial fibrillation: their mechanism and origination // Circulation. 2008. — V.117. — №.19. -P.244.
97. Moe GK, Rheinboldt WD, Abildskov JA. A computer model of atrial fibrillation // Am. Heart. J. 1964. — P.200 -220.
98. Morillo CA, Klein GJ, Jones DL. et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation// Circulation. 1995. — V.91. -P.1588 -95.
99. Murgatroyd FD, Gibson SM, Baiyan X. et al. Double-blind placebocontrolled trial of digoxin in symptomatic paroxysmal atrial fibrillation // Circulation. 1999. — V.99. — P.2765−70.
100. Nademanee K, McKenzie J, Kosar E. et. al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate // J. Am. Coll. Cardiol. 2004. — V.43. — P.2044 -2053.
101. Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts // Circulation. 1966. — V.34. -P.412- 422.
102. Nattel S. New ideas about atrial fibrillation 50 years on // Nature. 2002. -V.415. — P.219−226.
103. Nieuwlaat R, Capucci A, Camm AJ. et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation // Eur. Heart. J. 2005. — V.26. — P.2422−34.
104. Oral H, Chugh A, Good E. et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation // Circulation. 2006. — V. 113. — P. 1824 -1831.
105. Oral H, Chugh A, Ozaydin M. et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation // Circulation. -2006.- V. 114.- P.759−765.
106. Oral H, Knight BP, Ozaydin M. et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights // Circulation. -2002. -V. 106. P. 1256−1262.
107. Oral H, Scharf C, Chugh A. et. al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation // Circulation. 2003. — V.108. — P.2355—2360.
108. Ouyang F, Bansch D, Ernst S. et al. Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation // Circulation. 2004. — V. 110. — P.2090 -2096.
109. Pachon J.C., Pachon E.I., Pachon J.C. et al. A new treatment for atrial fibrillation based on spectral analysis to guide the catheter RF-ablation // Europace. -2004. V.6. — P.590−601.
110. Packer D.L., Keelan P., Munger T.M. et al. Clinical Presentation, Investigation, and Management of Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation // Circulation. 2005. — V. l 11. — P.546−554.
111. Pappone C, Augello G, Sala S, Gugliotta F. et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study // J. Am. Coll. Cardiol. 2006. -V.48. — P.2340 -2347.
112. Pappone C, Oreto G, Lamberti F. et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system // Circulation. 1999. — V. l00. — P. 12 031 208.
113. Pappone C, Rosanio S, Oreto G. et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation // Circulation. 2000. — V. l02. — P.2619 -2628.
114. Pappone C, Santinelli V, Manguso F. et al. Pulmonary vein denervation enhances longterm benefit after circumferential ablation for paroxysmal atrial fibrillation // Circulation. 2004. — V.109. — P.327−334.
115. Pappone C, Santinelli V. Segmental pulmonary vein isolation versus the circumferential approach: is the tide turning? // Heart Rhythm. 2004. — V.3. -P.326−8
116. Patterson E, Po SS, Scherlag BJ, Lazzara R. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation // Heart Rhythm. 2005. -V.2. — P.624−631.
117. Perez-Lugones A, McMahon JT, Ratliff NB. et al. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation // J. Cardiovasc. Electrophysiol. 2003. — V.14. — P.803- 809.
118. Petersen P, Madsen EB, Brun B. et al. Silent cerebral infarction in chronic atrial fibrillation // Stroke. 1987. -V. 18. — P. 1098 -100.
119. Polontchouk L, Haefliger JA, Ebelt B. et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria // J. Am. Coll. Cardiol. -2001.-V.38.-P.883−91.
120. Rajawat Y.S., Gerstenfeld E.P., Patel V.V. et al. ECG criteria for localizing the pulmonary vein origin of spontaneous atrial premature complexes: validation using intracardiac recordings // Pacing Clin. Electrophysiol. 2004. — V.27 — P.182−188.
121. Rocken C, Peters B, Juenemann G. et al. Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation // Circulation. 2002. -V.106. — P.2091−7.
122. Rostagno C., Olivo G., Comeglio M. Left atrial size changes in patients with paroxysmal lone atrial fibrillation. An echocardiographic follow-up // Angiology. -1996. V.47, № 8. — P.797−801.
123. Rostock T., Lutomsky B., Steven D., Willems S. The coronary sinus as a focal source of paroxysmal atrial fibrillation: more evidence for the 'fifth pulmonary vein'? // Pacing Clin. Electrophysiol. 2007. — V.30, № 8. — P. 1027−31.
124. Sahadevan J, Ryu K, Peltz L. et. al. Epicardial mapping of chronic atrial fibrillation in patients: preliminary observations // Circulation. 2004. — V.110. -P.3293−3299.
125. Sanders P, Berenfeld O, Hocini M. et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans // Circulation. -2005. V. l 12. -P.789 -797.
126. Sanders P, Morton JB, Davidson NC. et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans // Circulation. 2003. — V. l08. — P. 1461- 8.
127. Sarmast F, Kolli A, Zaitsev A. et al. Cholinergic atrial fibrillation: I (K, ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics // Car-diovasc. Res. 2003. — V.59. — P.863- 873.
128. Sauer WH, Alonso C, Zado E. et al. Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow-pathway modification // Circulation. 2006. — V. l 14. — P. 191 195.
129. Scanavacca M., Pisani F.C., Hachul D. et al. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation // Circulation. 2006. — V. 114. — P.876−885.
130. Scherf D. Studies on auricular tachycardia caused by aconitine administration // Proc. Soc. Exp. Biol. Med. 1947. — V.4. — P.233−239.
131. Scherlag BJ, Nakagawa H, Jackman WM. et. el. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation // J. Interv. Card. Electrophysiol. 2005. — V.13(Suppl 1). — P.37- 42.
132. Schmitt C., Ndrepepa G., Weber S. et al. Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation // Am. J. Cardiol. -2002. V.15, № 89(12). — P.1381−7.
133. Shah D, Haissaguerre M, Jais P, Hocini M. Nonpulmonary vein foci: do they exist? //Pacing Clin. Electrophysiol. -2003. V.26(7 Pt 2). -P.1631−1635.
134. Sharifov OF, Fedorov VV, Beloshapko GG. et. al. Roles of adrenergic and cholinergic stimulation in spontaneous atrial fibrillation in dogs // J. Am. Coll. Cardiol. 2004. — V.43. — P.483- 490.
135. Shauerte P., Scharlag B.J., Pitha J. et, al. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation // Circulation. — 2000. -V.102. -P.2774−2780.
136. Shi Y, Li D, Tardif JC. et al. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure // Cardiovasc. Res. 2002. — V.54. -P.456−61.
137. Shiroshita-Takeshita A, Brundel BJ, Nattel S. Atrial fibrillation: basic mechanisms, remodeling and triggers // J. Interv. Card. Electrophysiol. 2005. — V.13. -P.181−193.
138. Singh S., Johnson P.I., Lee R.E. et al. Topography of cardiac ganglia in the adult human heart // J. Thorac. Cardiovasc. Surg. 1996. — V. l 12. — P.943−953.
139. Singh SN, Tang XC, Singh BN. et al. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy // J. Am. Coll. Cardiol. 2006. -V.48. — P.721−730.
140. Skanes AC, Mandapati R, Berenfeld O. et. al. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart // Circulation. — 1998. V.98. — P.1236 -1248.
141. Stewart S, Hart CL, Hole DJ. et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study // Am. J. Med. 2002. — V. l 13. — P.359−64.
142. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study // Am. J. Med. 2002. — V. l 13. — P.359 -364.
143. Stewart S, Maclntyre K, MacLeod MM. et al. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986−1996 // Eur. Heart. J. 2001. — V.22. — 693−701.
144. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study. Final results // Circulation. 1991. — V.84. -P.527−39.
145. Sueda T, Imai K, Ishii O. et. al. Efficacy of pulmonary vein isolation for the elimination of chronic atrial fibrillation in cardiac valvular surgery // Ann. Thorac. Surg. 2001. — V.71. — P. l 189 -1193.
146. Sundt TM III, Camillo CJ, Cox JL. The maze procedure for cure of atrial fibrillation // Cardiol. Clin. 1997. — V.15. — P.739 -748.
147. Swartz JF, Pellerseis G, Silvers J. et. al. A catheter based curative approach to atrial fibrillation in humans // Circulation. 1994. — V.90(Supp). — P. 1−335.
148. Tai CT, Chen SA, Tzeng JW. et al. Prolonged fractionation of paced right atrial electrograms in patients with atrial flutter and fibrillation // J. Am. Coll. Cardiol. 2001. — V.37. — P. 1651−7.
149. Takahashi A, Iesaka Y, Takahashi Y. et al. Electrical connections between pulmonary veins: implication for ostial ablation of pulmonary veins in patients with paroxysmal atrial fibrillation // Circulation. 2002. — V. l05. — P.2998−3003.
150. Tanner H, Hindricks G, Kobza R. et. al. Trigger activity more than three years after left atrial linear ablation without pulmonary vein isolation in patients with atrial fibrillation // J. Am. Coll. Cardiol. 2005. — V.46. — P.338 -343.
151. Van G I, Hagens VE, Bosker HA. et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation // N. Engl. J. Med. 2002. — V.347. — P. 1834 -1840.
152. Verheule S, Wilson E, Everett T. et al. Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation // Circulation. 2003. — V.107. — P.2615−22.
153. Villecco AS, Pilati G, Bianchi G, Zanardi L. Left atrial size in paroxysmal atrial fibrillation: echocardiographic evaluation and follow-up // Cardiology. -1992. V.80, № 2. — P.89−93.
154. Wattigney WA, Mensah GA, Croft JB. Increased atrial fibrillation mortality: United States, 1980−1998 // Am. J. Epidemiol. 2002. — V.155. — P.819−826.
155. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention // Circulation. 2003. — V.108. — P.711- 6.
156. Wazni OM, Marrouche NF, Martin DO. et al. Radio frequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial // JAMA. 2005. — V.293. — P.2634 -2640.
157. Weerasooriya R, Jais P, Scavee C. et al. Dissociated pulmonary vein arrhythmia: incidence and characteristics // J. Cardiovasc. Electrophysiol. 2003. — V.14. -P.1173−1179.
158. Weiss C, Gocht A, Willems S. et. al. Impact of the distribution and structure of myocardium in the pulmonary veins for radiofrequency ablation of atrial fibrillation // Pacing Clin. Electrophysiol. 2002. — V.25. — P. 1352−1356.
159. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991−22:983- 8
160. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study // Stroke. 1991. — V.22. — P.983- 8.
161. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study // Arch. Intern. Med. 1987. -V.147. -P.1561−4.
162. Wongcharoen W, Chen YC, Chen YJ. et. al. Effects of a Na/Ca2 exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhyth-mogenicity // Cardiovasc. Res. 2006. — V.70. — P.497−508.
163. Wyse DG, Waldo AL, DiMarco JP. et al. A comparison of rate control and rhythm control in patients with atrial fibrillation // N. Engl. J. Med. 2002. — V.347. — P.1825−1833.
164. Zhou J, Scherlag B, Edwards J. et. al. Gradient of atrial refractoriness and in-ducibility of atrial fibrillation due to stimulation of ganglionated plexi // J. Cardio-vasc. Electrophysiol. 2007. — V.18. — P.83−90.
165. Zipes DP, Knope RF. Electrical properties of the thoracic veins// Am. J. Cardiol. 1972. — V.29. — P.372−376.